• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简化版老年评估和老年预后指数的验证和修改:弥漫性大 B 细胞淋巴瘤老年患者的有效工具。

Validation and modification of simplified Geriatric Assessment and Elderly Prognostic Index: Effective tools for older patients with diffuse large B-cell lymphoma.

机构信息

Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P.R. China.

Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Cancer Med. 2024 Jan;13(1):e6856. doi: 10.1002/cam4.6856. Epub 2023 Dec 22.

DOI:10.1002/cam4.6856
PMID:38132832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10807600/
Abstract

Geriatric assessment can aid in optimizing treatment strategies and supportive interventions for older patients with diffuse large B-cell lymphoma (DLBCL). Fondazione Italiana Linformi has recently introduced novel geriatric assessment tools, simplified Geriatric Assessment (sGA) and Elderly Prognostic Index (EPI), aimed at tailoring the treatment and predicting the outcomes for older patients with DLBCL. The objectives of this study are the validation and possible modification of the sGA and EPI in China. In the study, both sGA and EPI demonstrated the predictive capabilities for overall survival (OS) and early mortality (both p < 0.05) in older individuals with DLBCL. Albumin, serving as an independent predictive biomarker for OS (p = 0.006), was utilized to adjust the measurements, resulting in the establishment of sGA-A and EPI-A. The sGA-A effectively addressed the shortcomings of the sGA and EPI in predicting PFS and surpassed them in predicting OS and early mortality. Nevertheless, there is insufficient evidence to support the use of sGA and EPI as treatment guidance tools. In conclusion, the modified sGA-A model proved to be a successful instrument for geriatric assessment of older patients with DLBCL.

摘要

老年评估有助于优化弥漫性大 B 细胞淋巴瘤 (DLBCL) 老年患者的治疗策略和支持性干预措施。意大利林福明基金会 (Fondazione Italiana Linformi) 最近引入了新的老年评估工具,简化的老年评估 (sGA) 和老年预后指数 (EPI),旨在为 DLBCL 老年患者量身定制治疗方案并预测其结局。本研究旨在验证并可能修改中国的 sGA 和 EPI。在这项研究中,sGA 和 EPI 均显示出对 DLBCL 老年患者总生存 (OS) 和早期死亡率的预测能力 (均 p<0.05)。白蛋白是 OS 的独立预测生物标志物 (p=0.006),用于调整测量值,建立了 sGA-A 和 EPI-A。sGA-A 有效地解决了 sGA 和 EPI 在预测 PFS 方面的不足,并在预测 OS 和早期死亡率方面优于它们。然而,目前尚无足够的证据支持将 sGA 和 EPI 作为治疗指导工具。总之,改良后的 sGA-A 模型被证明是评估 DLBCL 老年患者的一种成功的老年评估工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6178/10807600/0df57c94e4b8/CAM4-13-e6856-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6178/10807600/fc6949a18178/CAM4-13-e6856-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6178/10807600/2fe7d3bf1361/CAM4-13-e6856-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6178/10807600/4ab08534fe98/CAM4-13-e6856-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6178/10807600/0df57c94e4b8/CAM4-13-e6856-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6178/10807600/fc6949a18178/CAM4-13-e6856-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6178/10807600/2fe7d3bf1361/CAM4-13-e6856-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6178/10807600/4ab08534fe98/CAM4-13-e6856-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6178/10807600/0df57c94e4b8/CAM4-13-e6856-g002.jpg

相似文献

1
Validation and modification of simplified Geriatric Assessment and Elderly Prognostic Index: Effective tools for older patients with diffuse large B-cell lymphoma.简化版老年评估和老年预后指数的验证和修改:弥漫性大 B 细胞淋巴瘤老年患者的有效工具。
Cancer Med. 2024 Jan;13(1):e6856. doi: 10.1002/cam4.6856. Epub 2023 Dec 22.
2
Comparative Effectiveness of R-miniCOMP Versus R-miniCHOP in Older Non-Fit Patients With Diffuse Large B-Cell Lymphoma: Insights From a "Fondazione Italiana Linfomi" Cohort Study.R-miniCOMP与R-miniCHOP方案治疗老年非适合弥漫性大B细胞淋巴瘤患者的疗效比较:来自意大利淋巴瘤基金会队列研究的见解
Hematol Oncol. 2025 May;43(3):e70099. doi: 10.1002/hon.70099.
3
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi.简化版老年综合评估在弥漫大 B 细胞淋巴瘤老年患者中的应用:意大利淋巴瘤基金会的前瞻性老年项目。
J Clin Oncol. 2021 Apr 10;39(11):1214-1222. doi: 10.1200/JCO.20.02465. Epub 2021 Feb 12.
4
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.老年预后指数可预测老年弥漫性大B细胞淋巴瘤患者的早期死亡率。意大利淋巴瘤基金会对老年项目的一项专项分析。
Hematol Oncol. 2023 Feb;41(1):78-87. doi: 10.1002/hon.3081. Epub 2022 Oct 7.
5
Geriatric screening tools predict survival outcomes in older patients with diffuse large B cell lymphoma.老年综合评估工具预测老年弥漫大 B 细胞淋巴瘤患者的生存结局。
Ann Hematol. 2019 Mar;98(3):669-678. doi: 10.1007/s00277-018-3551-y. Epub 2018 Nov 15.
6
Comprehensive Geriatric Assessment (CGA): A Simple Tool for Guiding the Treatment of Older Adults with Diffuse Large B-Cell Lymphoma in China.全面老年评估(CGA):指导中国老年弥漫大 B 细胞淋巴瘤患者治疗的简单工具。
Oncologist. 2020 Aug;25(8):e1202-e1208. doi: 10.1634/theoncologist.2019-0738. Epub 2020 Jun 11.
7
Association of the Geriatric 8 with treatment intensity and prognosis in older patients with diffuse large B-cell lymphoma.老年 8 项与老年弥漫性大 B 细胞淋巴瘤患者治疗强度和预后的关系。
Br J Haematol. 2021 Jul;194(2):325-335. doi: 10.1111/bjh.17554. Epub 2021 May 26.
8
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).85 岁及以上高龄的弥漫性大 B 细胞淋巴瘤患者可以从有治愈意图的治疗中获益:这是一项在前瞻性注册于意大利淋巴瘤基金会(FIL)老年项目中的 129 例患者的报告。
Haematologica. 2023 Apr 1;108(4):1083-1091. doi: 10.3324/haematol.2022.281407.
9
Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment.老年弥漫大 B 细胞淋巴瘤患者的年龄、合并症和白蛋白指数的验证和修正:全面老年评估的有效工具。
Oncologist. 2018 Jun;23(6):722-729. doi: 10.1634/theoncologist.2017-0361. Epub 2018 Jan 9.
10
Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study.老年弥漫性大 B 细胞淋巴瘤患者的老年风险模型(GERIAD):一项前瞻性多中心队列研究。
Korean J Intern Med. 2024 May;39(3):501-512. doi: 10.3904/kjim.2023.265. Epub 2024 Jan 30.

引用本文的文献

1
A simplified geriatric prognostic index to survival in older Asian patients with diffuse large B-Cell lymphoma treated with standard chemo-immunotherapy.一种用于接受标准化疗免疫疗法治疗的亚洲老年弥漫性大B细胞淋巴瘤患者生存情况的简化老年预后指数。
Ann Hematol. 2024 Dec;103(12):5663-5671. doi: 10.1007/s00277-024-06065-4. Epub 2024 Nov 26.
2
Hematological Malignancies in Older Patients: Focus on the Potential Role of a Geriatric Assessment Management.老年患者的血液系统恶性肿瘤:聚焦老年评估管理的潜在作用
Diagnostics (Basel). 2024 Jun 29;14(13):1390. doi: 10.3390/diagnostics14131390.

本文引用的文献

1
Treatment Individualization in Diffuse Large B-Cell Lymphoma: Is Frailty Enough for Old Adults? An Original Article.弥漫性大 B 细胞淋巴瘤的个体化治疗:虚弱是否足以适用于老年患者?一项原创文章。
Clin Lymphoma Myeloma Leuk. 2023 Oct;23(10):e348-e359. doi: 10.1016/j.clml.2023.06.010. Epub 2023 Jun 26.
2
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma.衰弱评分在预测老年弥漫性大 B 细胞淋巴瘤患者预后和个体化治疗强度中的作用。
Ann Hematol. 2023 Jun;102(6):1485-1500. doi: 10.1007/s00277-023-05233-2. Epub 2023 Apr 28.
3
Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study.
老年弥漫大 B 细胞淋巴瘤患者的肌肉减少症、老年综合评估和营养评估的预后相关性:一项多中心前瞻性队列研究的结果。
Ann Hematol. 2023 Jul;102(7):1811-1823. doi: 10.1007/s00277-023-05200-x. Epub 2023 Apr 14.
4
The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy.老年预后指数:一种用于预测接受标准免疫化疗的老年弥漫性大 B 细胞淋巴瘤患者生存的临床预测模型。
Haematologica. 2023 Sep 1;108(9):2454-2466. doi: 10.3324/haematol.2022.282289.
5
How I treat older patients with DLBCL in the frontline setting.我在一线治疗老年弥漫性大 B 细胞淋巴瘤患者的方法。
Blood. 2023 May 25;141(21):2566-2575. doi: 10.1182/blood.2020008239.
6
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).85 岁及以上高龄的弥漫性大 B 细胞淋巴瘤患者可以从有治愈意图的治疗中获益:这是一项在前瞻性注册于意大利淋巴瘤基金会(FIL)老年项目中的 129 例患者的报告。
Haematologica. 2023 Apr 1;108(4):1083-1091. doi: 10.3324/haematol.2022.281407.
7
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.老年预后指数可预测老年弥漫性大B细胞淋巴瘤患者的早期死亡率。意大利淋巴瘤基金会对老年项目的一项专项分析。
Hematol Oncol. 2023 Feb;41(1):78-87. doi: 10.1002/hon.3081. Epub 2022 Oct 7.
8
Chemotherapy-free treatment in unfit patients aged 75 years and older with DLBCL: toward a new paradigm?75岁及以上不适合接受化疗的弥漫性大B细胞淋巴瘤患者的无化疗治疗:迈向新范式?
Lancet Healthy Longev. 2022 Jul;3(7):e453-e454. doi: 10.1016/S2666-7568(22)00150-7.
9
Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤中 R-CHOP 的理想剂量强度。
Expert Rev Anticancer Ther. 2022 Jun;22(6):583-595. doi: 10.1080/14737140.2022.2071262. Epub 2022 May 5.
10
G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.G8 和 VES-13 作为老年综合评估的筛查工具及预测印度老年癌症患者生存的指标。
J Geriatr Oncol. 2022 Jun;13(5):720-730. doi: 10.1016/j.jgo.2022.02.013. Epub 2022 Mar 10.